Description

5-Bromo-3-(Hexahydro-4-Methyl-1H-1,4-Diazepin-1-Yl)-2-Pyrazinamine CAS NO 894807-97-7 is a high-purity, heterocyclic organic compound featuring a pyrazinamine core substituted with a bromine atom and a diazepine ring system. This specific molecular architecture makes it a critical intermediate for advanced pharmaceutical research and development, particularly in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought after by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the development of new therapeutic agents.

Application

• Pharmaceutical Intermediate: Serves as a key building block in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders and other therapeutic areas.
• Active Pharmaceutical Ingredient (API) Development: Used in research-scale and process chemistry for the development and optimization of new API synthesis routes.
• Medicinal Chemistry Research: Employed as a versatile scaffold for structure-activity relationship (SAR) studies to explore new chemical entities with potential biological activity.
• Contract Research & Manufacturing (CRAM): Supplied to organizations providing custom synthesis and process development services for the global pharmaceutical industry.
• Biochemical Research: May be utilized as a specialized reagent or ligand in biochemical assays and proteomics research.

Basic Information

Product Name	5-Bromo-3-(Hexahydro-4-Methyl-1H-1,4-Diazepin-1-Yl)-2-Pyrazinamine
CAS No.	894807-97-7
Molecular Formula	C10H16BrN5
Molecular Weight	286.18 g/mol
Synonyms	5-Bromo-3-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)pyrazin-2-amine; 2-Pyrazinamine, 5-bromo-3-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-; 894807-97-7; 5-Bromo-3-(4-methyl-1,4-diazepan-1-yl)pyrazin-2-amine; 3-(1,4-Diazepan-1-yl)-5-bromopyrazin-2-amine derivative
EINECS	Contact for details

Quality Control

Our production of 5-Bromo-3-(Hexahydro-4-Methyl-1H-1,4-Diazepin-1-Yl)-2-Pyrazinamine adheres to stringent quality management protocols. Each batch undergoes comprehensive analytical testing, including HPLC, NMR, and MS, to ensure high chemical purity and structural identity. A detailed Certificate of Analysis (COA) is provided with every shipment, confirming compliance with agreed specifications. We support cGMP standards for materials intended for pharmaceutical research applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at controlled room temperature (15-25°C). The compound may be hygroscopic; keep the container tightly sealed in a dry environment.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.